European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study

RecruitingOBSERVATIONAL
Enrollment

2,300

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

January 30, 2030

Study Completion Date

January 30, 2030

Conditions
CIED Related Infection
Interventions
DEVICE

TauroPace™

TauroPace™ is intended to be used as a disinfecting solution during any CIED related surgery procedure or handling of any uncoated or silicon-, epoxy- or polyurethane-coated CIED (including its components, e.g., leads) made of titan or stainless steel in any adult patient requiring or carrying a CIED.

Trial Locations (8)

2700

NOT_YET_RECRUITING

Landeskrankenhaus Wiener Neustadt, Wiener Neustadt

24105

COMPLETED

University Hospital Schleswig-Holstein, Kiel

26954

RECRUITING

Helios Klinik Wesermarsch, Nordenham

27474

RECRUITING

Helios Klinik Cuxhaven, Cuxhaven

39100

NOT_YET_RECRUITING

Ospedale Regionale San Maurizio, Bolzano

69500

NOT_YET_RECRUITING

Louis Pradel Hospital, Lyon

84036

ACTIVE_NOT_RECRUITING

Krankenhaus Landshut Achdorf, Landshut

SN3 6BB

ACTIVE_NOT_RECRUITING

Great Western Hospitals NHS Foundation Trust, Swindon

All Listed Sponsors
collaborator

University of Luebeck

OTHER

lead

University of Kiel

OTHER